Are you looking for a new opportunity?
Remote work and a competitive rate (outside IR35)?
Then apply below!!
Are you an experienced Health Economic Modeler to help support global cost-effectiveness model development and adaptation across two of our oncology indications (adjuvant breast cancer and advanced prostate cancer). You will work closely with our Health Economic and Payer Evidence Director, as well as working alongside our payer biostatistics team, pricing and market access colleagues, and innovative value strategies team.
Given the technical aspect of the role, you must have strong capabilities in economic modelling using Excel and VBA, and experience in HTA standard oncology cost-effectiveness models. Knowledge of breast cancer and prostate cancer is desirable, although not essential if you have experience of other tumor types. Ability to undertake network meta analyses would be a benefit, including familiarity with R, although these too are not essential.
Good communication skills are important to ensure optimal collaboration with colleagues, including our local affiliates where needed. There may also be a need to write up methods and results, so good technical writing skills are also important.
